NAALADL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.711400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.859000E-01
Normal-vs-Stage2
5.111800E-01
Normal-vs-Stage3
5.861600E-01
Normal-vs-Stage4
2.368200E-01
Stage1-vs-Stage2
7.424200E-01
Stage1-vs-Stage3
2.656600E-01
Stage1-vs-Stage4
5.538600E-01
Stage2-vs-Stage3
1.473160E-01
Stage2-vs-Stage4
2.171400E-01
Stage3-vs-Stage4
4.033800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.873800E-01
Normal-vs-AfricanAmerican
4.607600E-01
Normal-vs-Asian
7.857600E-01
Caucasian-vs-AfricanAmerican
3.574200E-01
Caucasian-vs-Asian
6.344800E-01
AfricanAmerican-vs-Asian
3.409200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.408400E-01
Normal-vs-Female
6.235600E-01
Male-vs-Female
6.566200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.006600E-01
Normal-vs-Age(41-60Yrs)
3.965200E-01
Normal-vs-Age(61-80Yrs)
6.964000E-01
Normal-vs-Age(81-100Yrs)
7.216600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.494200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.434400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.723000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.899800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.461200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.691000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.250000E-01
Normal-vs-Daily Drinker
9.302600E-01
Normal-vs-Weekly Drinker
8.761800E-01
Normal-vs-Occasional Drinker
6.258000E-01
Normal-vs-Social Drinker
8.787800E-01
Non Drinker-vs-Daily Drinker
3.951700E-02
Non Drinker-vs-Weekly Drinker
6.857700E-02
Non Drinker-vs-Occasional Drinker
5.601000E-01
Non Drinker-vs-Social Drinker
1.469600E-01
Daily Drinker-vs-Weekly Drinker
8.623800E-01
Daily Drinker-vs-Occasional Drinker
2.036200E-01
Daily Drinker-vs-Social Drinker
6.374800E-01
Weekly Drinker-vs-Occasional Drinker
2.407400E-01
Weekly Drinker-vs-Social Drinker
5.768000E-01
Occasional Drinker-vs-Social Drinker
4.262800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.337770E-01
Normal-vs-Grade 2
1.922350E-02
Normal-vs-Grade 3
3.908300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.013600E-02
Grade 1-vs-Grade 3
1.126360E-02
Grade 1-vs-Grade 4
1.337770E-01
Grade 2-vs-Grade 3
2.626800E-01
Grade 2-vs-Grade 4
1.922350E-02
Grade 3-vs-Grade 4
3.908300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.552800E-01
Normal-vs-NonDiabetic
6.026800E-01
Diabetic-vs-NonDiabetic
4.664400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.907200E-01
Normal-vs-NoPancreatitis
6.353800E-01
Pancreatitis-vs-NoPancreatitis
9.649600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.579600E-01
Normal-vs-N1
4.699000E-01
N0-vs-N1
1.186380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.531000E-01
Normal-vs-TP53-NonMutant
5.338400E-01
TP53-Mutant-vs-TP53-NonMutant
6.352100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
